NecroFerrins as dual therapeutic inhibitors targeting necroptosis and ferroptosis
Ferroptosis and Oxidative Stress · 2026
DOI: 10.70401/fos.2026.0041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ferroptosis and Oxidative Stress, 2026. Verfasst von Claire Delehouzé und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Over the past two decades, increasing attention has been devoted to regulated forms of cell death that occur independently of apoptosis. Among these, necroptosis and ferroptosis exhibit a necrotic-like morphology, yet are defined by distinct molecular and biochemical signatures. Both pathways have attracted considerable interest due to growing evidence implicating them in the pathogenesis of a wide range of acute and chronic disorders. Notably, the simultaneous engagement of multiple regulated necrosis pathways has been reported in many disease contexts, highlighting the limitations of single-target therapeutic approaches. In this light, the design of multi-target-directed ligands, that is, embracing a polypharmacological strategy, has emerged as a promising direction for the development of future therapies. In this review, we propose the concept of NecroFerrins, a class of small molecules that simultaneously inhibit necroptosis and ferroptosis. Within this class, we identify RIPROStatins as a distinct subclass of RIPK1 inhibitors that additionally possess radical-trapping antioxidant activity. The objective of this review is also to stimulate translational research on complex diseases using polypharmacological drugs acting as necrosis inhibitors.
Zitieren
APA
Delehouzé, C., & Bach, S. (2026). NecroFerrins as dual therapeutic inhibitors targeting necroptosis and ferroptosis. Ferroptosis and Oxidative Stress. https://doi.org/10.70401/fos.2026.0041
Vancouver
Delehouzé C, Bach S. NecroFerrins as dual therapeutic inhibitors targeting necroptosis and ferroptosis. Ferroptosis and Oxidative Stress. 2026. doi:10.70401/fos.2026.0041
BibTeX
@article{Delehouz2026,
author = {Delehouzé, Claire and Bach, Stéphane},
title = {NecroFerrins as dual therapeutic inhibitors targeting necroptosis and ferroptosis},
journal = {Ferroptosis and Oxidative Stress},
year = {2026},
doi = {10.70401/fos.2026.0041}
}
EUVIMED